OREXO AB SP/ADR (ORXOY)
News Quantified tracks ORXOY headlines — 63 labeled events over the last three years — but too few produced usable price reactions to publish stable medians. The events themselves are below.
Not enough usable reactions to publish ORXOY medians.
63 ORXOY events are labeled, but too few carry a measurable price reaction for a median to mean anything. When enough reactions accumulate, the medians publish here the same way as every other name.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ORXOY moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ORXOY's baseline. Nothing else.
Recent ORXOY events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Orexo to present clinical data for OX640 at the EAACI Congress | Press release | PR Newswire | — | — | |
| Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology | Press release | PR Newswire | — | — | |
| Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis | Press release | PR Newswire | — | — | |
| Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology | Press release | PR Newswire | +0.00% | +0.00% | |
| Orexo initiates new study of OX640 in participants with allergic rhinitis | Press release | PR Newswire | +0.00% | +0.00% | |
| Orexo Interim Report Q3 2024 | Press release | PR Newswire | — | — | |
| Orexo´s Nomination Committee for the Annual General Meeting 2025 | Press release | PR Newswire | — | — | |
| Orexo to participate in Pareto Securities´ 15th Annual Healthcare Conference 2024 | Press release | PR Newswire | — | — | |
| Orexo Q2 2024 Interim Report | Press release | PR Newswire | +0.00% | +12.97% | |
| Orexo shares new information on OX124, a high-dose naloxone rescue medication in development for opioid overdose | Press release | PR Newswire | — | +0.00% | |
| Orexo AB´s sustainability work ranked among top 5% by EcoVadis | Press release | PR Newswire | +0.00% | +0.00% | |
| Orexo: invitation to presentation of the Q2 2024 Interim Report | Press release | PR Newswire | +0.00% | +0.00% | |
| Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm | Press release | PR Newswire | — | — | |
| Orexo Q1 2024 Interim Report | Press release | PR Newswire | — | — | |
| Report from Orexo AB's annual general meeting, 26 April 2024 | Press release | PR Newswire | — | — | |
| Orexo extends patent protection for its nasal epinephrine powder product OX640 in the US | Press release | PR Newswire | — | — | |
| Orexo announces that the condition for early redemption of its existing bonds has been fulfilled | Press release | PR Newswire | — | — | |
| Orexo publishes the Annual and Sustainability Report for 2023 | Press release | PR Newswire | — | — | |
| Correction: Notice of Annual General Meeting of Orexo | Press release | PR Newswire | +0.00% | +0.00% | |
| Notice of Annual General Meeting of Orexo | Press release | PR Newswire | — | — | |
| Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds | Press release | PR Newswire | +0.00% | +0.00% | |
| Orexo contemplates issuance of senior secured callable floating rate social bonds and announces a conditional tender offer for its existing bonds | Press release | PR Newswire | — | — | |
| Orexo strengthens its sustainability work by establishing a social financing framework | Press release | PR Newswire | — | — | |
| Orexo and Sobi agree to advance feasibility study with AmorphOX | Press release | PR Newswire | — | — | |
| Orexo Interim Report Q4 2023, incl. Full Year Report | Press release | PR Newswire | — | — | |
| Orexo's OX640 development results to be presented at the 2024 AAAAI Annual Meeting in Washington, DC | Press release | PR Newswire | — | — | |
| Orexo announces FDA acceptance of New Drug Application filing for OX124, a high-dose rescue medication for opioid overdose | Press release | PR Newswire | — | — | |
| Orexo Q3 2023 Interim Report | Press release | PR Newswire | — | — | |
| Orexo announces changes in the company´s Board of Directors | Press release | PR Newswire | — | — | |
| Orexo´s Nomination Committee for the Annual General Meeting 2024 | Press release | PR Newswire | — | — | |
| Report from Orexo´s extraordinary general meeting | Press release | PR Newswire | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ORXOY section they belong to.
Where else ORXOY is measured.
ORXOY earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Spectral Medical Inc (EDT_TSE) | 63 | 0.00% | 38% |
| Infinity Pharmaceuticals, Inc. (INFI) | 63 | +3.96% | 71% |
| Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) | 62 | 0.00% | 40% |
| LIFT & CO CORP (LIFT_CDNX) | 62 | -0.52% | 27% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.